Full House Without Lupus: Diagnostic and Therapeutic Challenges in a Seronegative Patient (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0791; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received rituximab (RTX) 1g x 2...She was transitioned to MMF with a prednisone taper...Obinutuzumab showed higher remission rates than RTX retreatment in refractory MN (54.6% vs 9.1%) & represents the best rescue therapy. In conclusion, iFH-N needs early diagnosis, prompt treatment, clinicopathologic correlation, and long-term follow-up."
Clinical • Chronic Kidney Disease • Endocrine Disorders • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Nephrology • Renal Disease
|
|
Syed Sadam Hussain; Daneet Kumar; Wajid Ali; Faryal Masaud; Latif Salam
|